BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31646558)

  • 1. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways.
    Yan PH; Wang L; Chen H; Yu FQ; Guo L; Liu Y; Zhang WJ; Bai YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8287-8294. PubMed ID: 31646558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
    Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
    Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration.
    Shi J; Zhong X; Song Y; Wu Z; Gao P; Zhao J; Sun J; Wang J; Liu J; Wang Z
    Cell Biochem Funct; 2019 Jan; 37(1):11-20. PubMed ID: 30499136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
    Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
    Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
    Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
    J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway.
    Zhang Y; Mi L; Xuan Y; Gao C; Wang YH; Ming HX; Liu J
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4861-4868. PubMed ID: 30070317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
    Li H; Yuan R; Wang H; Li C; Wei J
    J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ; Sui MH; Sun ZX; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
    Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LncRNA RUNX1-IT1 regulating malignant pleomorphic adenoma via mir-195/CyclinD1].
    Wei JS; Sun X; Xu JB; Chen YD
    Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):85-90. PubMed ID: 36973850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of long non-coding ribonucleic acid (lncRNA) RUNX1-IT1 promotes the proliferation and stemness of lung cancer cells.
    Miao Y; Li T; Liu Y; Yu Y; Wu J
    Transl Cancer Res; 2021 Nov; 10(11):4884-4893. PubMed ID: 35116340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MT1JP inhibits the malignant progression of hepatocellular carcinoma through regulating AKT.
    Wu JH; Xu K; Liu JH; Du LL; Li XS; Su YM; Liu JC
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6647-6656. PubMed ID: 32633354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion.
    Liu S; Zhang J; Yin L; Wang X; Zheng Y; Zhang Y; Gu J; Yang L; Yang J; Zheng P; Jiang Y; Shuai L; Cai X; Wang H
    Cell Death Dis; 2020 Jun; 11(6):412. PubMed ID: 32487998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.